Initiation of Phase 1b Study of GT-02287 in Parkinson's patients expected by end of 2024 BETHESDA, Md., Nov. 14, 2024 (GLOBE ...
A team of Tel Aviv University researchers claims to have made progress in the path to treating Parkinson’s disease. The team found that a variant of a protein, caused by a genetic mutation, enhances ...
Tel Aviv University researchers have made a discovery that could enhance our understanding of genetic mutations and their ...
Researchers used base and prime editing to uncover new EGFR gene mutations that affect cancer progression and drug resistance ...
Personalised nutrition strategies, which take into account genetic makeup, lifestyle, and individual health conditions, are ...